Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Transaction History

Paragon Associates & Paragon Associates Ii Joint Venture

$58.7 Million
Q2 2025

A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Iridex Corp stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 1,000,000 shares of IRIX stock, worth $1.32 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

1,000,000

Previous 1,000,000 -0.0%

Holding current value

$1.32 Million

Previous $990,000 11.11%

% of portfolio

1.5%

Previous 2.49%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.76 - $2.43 $38,649 - $53,362	-21,960 Reduced 2.15%	1,000,000 $2.17 Million
Q4 2022 Feb 13, 2023	BUY	$2.0 - $2.63 $445,150 - $585,372	222,575 Added 27.84%	1,021,960 $2.05 Million
Q3 2022 Nov 14, 2022	BUY	$2.41 - $3.41 $570,483 - $807,198	236,715 Added 42.07%	799,385 $1.93 Million
Q1 2022 May 16, 2022	BUY	$3.99 - $6.42 $260,678 - $419,437	65,333 Added 13.14%	562,670 $2.61 Million
Q4 2021 Feb 14, 2022	SELL	$5.62 - $9.37 $1.61 Million - $2.68 Million	-286,288 Reduced 36.53%	497,337 $3.04 Million
Q3 2021 Nov 15, 2021	SELL	$6.29 - $7.98 $1.24 Million - $1.57 Million	-197,049 Reduced 20.09%	783,625 $6 Million
Q2 2021 Aug 16, 2021	SELL	$6.67 - $9.2 $1.4 Million - $1.93 Million	-209,326 Reduced 17.59%	980,674 $6.92 Million
Q1 2021 May 14, 2021	SELL	$2.18 - $7.71 $283,400 - $1 Million	-130,000 Reduced 9.85%	1,190,000 $8.03 Million
Q3 2018 Nov 14, 2018	BUY	$6.0 - $9.15 $420,000 - $640,500	70,000 Added 5.6%	1,320,000 $8.38 Million
Q3 2017 Nov 13, 2017	BUY	$8.19 - $10.25 $10.2 Million - $12.8 Million	1,250,000	1,250,000 $11.7 Million

Others Institutions Holding IRIX

# of Institutions

Shares Held

2.69M

Call Options Held

36.1K

Put Options Held

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $21.1M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Associates & Paragon Associates Ii Joint Venture, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Associates & Paragon Associates Ii Joint Venture with notifications on news.

Account

Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Transaction History